在乳腺癌中识别HER2过度表达,HER2低表达和HER2零表达状态,基于F-FDG PET/CT放射学

Xuefeng Hou1,2,3, Kun Chen4, Huiwen Luo1,2,3

  • 1Department of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Huan-Hu-Xi Road, Ti-Yuan-Bei, He Xi District, Tianjin, 300060, China.

概括

这项研究表明,将PET/CT放射学与临床病理学数据相结合,可以在乳腺癌患者中非侵入性地预测人类表皮生长因子受体2 (HER2) 表达水平.